• Home
  • Submission
    • WMO applicable
    • Non WMO research
    • Approval Board of Directors UMCG
    • Biobank and/or databank
  • Documents
  • Topics
    • Adverse Events (SAEs, SUSARs, SADEs, etc.)
  • Contact & Info
    • Composition METc UMCG
    • METc UMCG meetings
    • METc UMCG Fee
    • More practical information
  • FAQ
  • News
    • Toolbox UMCG: update checklist with Site Suitability Form
    • What is the impact of the GDPR on the informed consent letter?
  • English
    • Dutch
Menu
  • Home
  • Submission
    • WMO applicable
    • Non WMO research
    • Approval Board of Directors UMCG
    • Biobank and/or databank
  • Documents
  • Topics
    • Adverse Events (SAEs, SUSARs, SADEs, etc.)
  • Contact & Info
    • Composition METc UMCG
    • METc UMCG meetings
    • METc UMCG Fee
    • More practical information
  • FAQ
  • News
    • Toolbox UMCG: update checklist with Site Suitability Form
    • What is the impact of the GDPR on the informed consent letter?
  • English
    • Dutch
Search
Close

Submission stop for trials with medical device

The European Medical Device Regulation (MDR) comes into effect per 26 May 2021. As a consequence the rules for submission, review en performance of clinical trials with medical devices change.

Trials with a medical device that have been approved by the METc UMCG before 26 May 2021 may continue according to current rules and regulation, with the exception of safety reporting which must adhere to the new Regulation per 26 May 2021 (article 80 MDR).

Trials with a medical device that have been submitted before 26 May 2021 but of which the review has not yet been concluded, must adhere to the new Regulation. There is NO transition period.

To prevent double reviews the METc UMCG has decided as of 1 March 2021 to not accept new submissions of trials that fall under article 62 and 74.2 of the MDR.

From 26 May 2021 trials that fall under article 62 and 74.2 of the MDR may be submitted to the METc UMCG.

Postmarketing clinical follow-up (article 74.1) or other (article 82) trials do not have to be resubmitted after 26 May 2021. Their review can be concluded according to current practise.

Do you have a trial with medical devices in review with the METc UMCG but the review is not yet finisched? The METc UMCG will make every effort to conclude the review as soon as possible.

If you have any questions regarding this post, please contact the secretariat of the METc UMCG (mailto: metc@umcg.nl)

Print or export to pdf
  • Home
  • Submission
  • Topics
  • FAQ
  • Documents
  • Information & contact
Menu
  • Home
  • Submission
  • Topics
  • FAQ
  • Documents
  • Information & contact

POWERED BY Wild Sea 2020

Manage Cookie Consent
Wij gebruiken cookies om onze website en onze service te optimaliseren.
Functionele cookies Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
Bekijk voorkeuren
{title} {title} {title}